Portfolio company
Abacus Bioscience
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This company develops active immunotherapies to treat cancer and chronic infections for patients requiring advanced medical treatments.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Avidicure
This biotechnology company develops multifunctional antibody therapies for cancer patients to activate immune responses while reducing toxicity.
Abalos Therapeutics
This company develops arenavirus-based immuno-virotherapies to treat solid tumours and metastases for patients with cancer.
Nykode Therapeutics
This company develops immunotherapy vaccines to treat patients with cancer and autoimmune diseases.
Alyssum Therapeutics
This company develops B cell-based targeted immunotherapies for patients with solid tumours and complex immunological conditions.
Abgentis
This company develops broad-spectrum antibacterial drugs for pharmaceutical firms to treat acute, chronic, and drug-resistant infections.
Abologix
The company develops monoclonal antibody therapeutics to treat drug-resistant lymphomas and solid tumours for cancer patients.
Bioarchitech
This company develops viral and RNA immunotherapies designed to help the immune systems of cancer patients target and destroy tumours.
Actym Therapeutics
This biotechnology company develops bacterial immunotherapies to treat solid tumours and fibrotic diseases for patients with advanced cancers.